Abstract P246: Soluble (pro)renin Receptor Induces Endothelial Cell Injury Via Activation of Nox4/NF-κB Pathway

Ziwei Fu,Jiajia Hu,Fei Wang,Jiahui Su,Xiaohan Lu,Tianxin Yang

DOI: https://doi.org/10.1161/hyp.70.suppl_1.p246

IF: 9.8968

2017-01-01

Hypertension

Abstract:Circulating soluble (pro)renin receptor (sPRR), the cleavage product of the extracellular domain of PRR, is elevated in patients with cardiovascular diseases, highlighting its value as a disease biomarker. We explored a potential biological effect of sPRR in vascular endothelial cells. In primary human umbilical vein endothelial cells (HUVECs), a 2-h treatment with a recombinant histidine-tagged sPRR (sPRR-His) at 50 nM decreased IκBα protein by 55%, associated with 1.5-fold increase in nuclear fraction protein abundance of NF-κB p65 as assessed by immunoblotting. By immunostaining, the increased p65 was localized to the nucleus. The NF-κB p65 transcription factor activity assay on the isolated nuclear fractions showed that the activity increased 1.9-fold after 2-h sPRR-His treatment. At 3 h of sPRR-His treatment, mRNA expression was increased 3.8-fold for IL-6, 30.8-fold for IL-8, 17.3-fold for VCAM-1, and 4.2-fold for ICAM-1 as assessed by qRT-PCR; ELISA detected a 2.6-fold increase in medium IL-6 and 3.7-fold increase in medium IL-8. Moreover, enhanced apoptosis was evidenced by a 2.9-fold increase of cleaved caspase 3 protein and a 4-fold increase in the apoptotic cell number, as assessed by immunoblotting and annexin V-FITC/PI double staining flow cytometry, respectively. In addition, sPRR-His induced a 69% decrease in phospho-eNOS (Ser1177) protein abundance. At 2 h, sPRR-His induced a 2.0-fold increase in Nox4 protein and a 2.8-fold increase in medium H2O2 as assessed by immunoblotting and ROS-Glo H2O2 assay, respectively. A Nox1/4 inhibitor GKT137892 and NADPH oxidase inhibitor apocynin completely abolished sPRR-His-induced NF-κB activation, cytokine production, and apoptosis, similar to the effect of NF-κB inhibition with PDTC. Overall, the present study for the first time reports that sPRR serves as a pro-inflammatory and pro-apoptotic mediator in vascular endothelial cells through activation of Nox4/NF-κB. These findings support PRR/sPRR as a potential target for treatment of cardiovascular disease.